Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
Go back to Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate| (NASDAQ: MDCX) | Delayed: 0.42 -0.04 (8.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.46 | 52 Week High | $ | |||
| Open | $0.46 | 52 Week Low | $ | |||
| Day High | $0.46 | P/E | N/A | |||
| Day Low | $0.40 | EPS | $ | |||
| Volume | 1,714,695 | |||||
| (NASDAQ: MDCX) | Delayed: 0.42 -0.04 (8.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.46 | 52 Week High | $ | |||
| Open | $0.46 | 52 Week Low | $ | |||
| Day High | $0.46 | P/E | N/A | |||
| Day Low | $0.40 | EPS | $ | |||
| Volume | 1,714,695 | |||||

